Hadjinor, Darwisa .

HRN: 21-10-43  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
CEFUROXIME 1.5GM (VIAL)
10/17/2023
10/17/2023
IVT
1.5 Gm
On Call To OR ANST
Repeat STAT CS
Waiting Final Action 
10/17/2023
CEFUROXIME 1.5GM (VIAL)
10/17/2023
10/24/2023
IVT
1.5 Gm
Q 8h IV X 4 Doses
S/P REPEAT LSCS
Waiting Final Action 
10/17/2023
CEFUROXIME 500MG (TAB)
10/17/2023
10/24/2023
PO
500 Mg Tab
BID
S/P REPEAT LSCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: